CAeditome Logo

Home

Download

Statistics

Landscape

Help

Contact
Center for Computational Systems Medicine
Soverview

1. Gene summary of enriched editing regions

Soverview

2. Tumor-specific enriched editing regions

Comparison of enriched editing regions between tumor and normal.

Correlation of enriched editing regions with tumor stages.

Associations of enriched editing regions with cancer survival.

Soverview

3. Enriched editing regions and immune related genes

Soverview

4. Enriched editing regions and immune related splicing

Soverview

5. Enriched editing regions and immune infiltration

Soverview

6. Enriched editing regions and immune gene sets

Correlation of enriched editing regions with epithelial-mesenchymal transition.

Correlations of enriched editing regions with hypoxic.

Associations of enriched editing regions with hallmark gene sets from MSigDB.

Soverview

7. Enriched editing regions and drugs

Correlations between enriched editing regions and drug sensitivity.

Enriched editing regions targeted by drugs from DrugBank database.

Editing gene: GSR (ImmuneEditome ID:2936)

1. Gene summary of enriched editing regions for GSR

check button Gene summary
Gene informationGene symbol

GSR

Gene ID

2936

GeneSynonymsGR|GSRD|HEL-75|HEL-S-122m
GeneCytomap

8p12

GeneTypeprotein-coding
GeneDescriptionglutathione reductase, mitochondrial|GRase|epididymis luminal protein 75|epididymis secretory sperm binding protein Li 122m|glutathione S-reductase
GeneModificationdate20230409
UniprotIDP00390;H0YC68
PubMed ID

check buttonUCSC image.
all structure

check buttonLocations of each EERs.
EERENSTENSGGeneNameRegionRepeatdsRNA structure
chr8:30678340-30679179:-ENST00000221130.8ENSG00000104687.11GSRUTR3AluJb,(AT)n,AluSpchr8:30678340-30679179:-.alignment
chr8:30692032-30692721:-ENST00000221130.8ENSG00000104687.11GSRintronicAluSz,AluJb,AluSpchr8:30692032-30692721:-.alignment
chr8:30692032-30692721:-ENST00000523295.4ENSG00000104687.11GSRintronicAluSz,AluJb,AluSpchr8:30692032-30692721:-.alignment
chr8:30692032-30692721:-ENST00000537535.4ENSG00000104687.11GSRintronicAluSz,AluJb,AluSpchr8:30692032-30692721:-.alignment
chr8:30692032-30692721:-ENST00000541648.4ENSG00000104687.11GSRintronicAluSz,AluJb,AluSpchr8:30692032-30692721:-.alignment
chr8:30692032-30692721:-ENST00000546342.4ENSG00000104687.11GSRintronicAluSz,AluJb,AluSpchr8:30692032-30692721:-.alignment
chr8:30697535-30697985:-ENST00000221130.8ENSG00000104687.11GSRintronicAluJo,AluJb,FLAM_Achr8:30697535-30697985:-.alignment
chr8:30697535-30697985:-ENST00000521479.1ENSG00000104687.11GSRintronicAluJo,AluJb,FLAM_Achr8:30697535-30697985:-.alignment
chr8:30697535-30697985:-ENST00000523295.4ENSG00000104687.11GSRintronicAluJo,AluJb,FLAM_Achr8:30697535-30697985:-.alignment
chr8:30697535-30697985:-ENST00000537535.4ENSG00000104687.11GSRintronicAluJo,AluJb,FLAM_Achr8:30697535-30697985:-.alignment
chr8:30697535-30697985:-ENST00000541648.4ENSG00000104687.11GSRintronicAluJo,AluJb,FLAM_Achr8:30697535-30697985:-.alignment
chr8:30697535-30697985:-ENST00000546342.4ENSG00000104687.11GSRintronicAluJo,AluJb,FLAM_Achr8:30697535-30697985:-.alignment


Top

2. Tumor-specific enriched editing regions for GSR


all structure

check buttonComparison of enriched editing regions between tumor and normal.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypePBoxplot
chr8:30678340-30679179:-BRCAEER1.0602e-49image
ENSG00000104687.11,GSRBRCAEAG9.8744e-50image
chr8:30678340-30679179:-COADEER5.7891e-11image
ENSG00000104687.11,GSRCOADEAG4.3210e-11image
chr8:30678340-30679179:-HNSCEER1.1935e-10image
ENSG00000104687.11,GSRHNSCEAG1.1935e-10image
ENSG00000104687.11,GSRKICHEAG3.1288e-03image
ENSG00000104687.11,GSRKIRCEAG3.2101e-02image
chr8:30678340-30679179:-KIRPEER4.5346e-07image
ENSG00000104687.11,GSRKIRPEAG4.7843e-07image
chr8:30678340-30679179:-LUADEER1.6215e-24image
ENSG00000104687.11,GSRLUADEAG1.5641e-24image
chr8:30678340-30679179:-LUSCEER1.8662e-05image
ENSG00000104687.11,GSRLUSCEAG1.8250e-05image
chr8:30678340-30679179:-STADEER5.4101e-06image
ENSG00000104687.11,GSRSTADEAG2.5294e-06image
chr8:30678340-30679179:-THCAEER2.4891e-15image
ENSG00000104687.11,GSRTHCAEAG2.4891e-15image
chr8:30678340-30679179:-UCECEER7.0372e-08image
ENSG00000104687.11,GSRUCECEAG6.3101e-08image


Top

check buttonCorrelation of enriched editing regions with tumor stages.
* AnovaP<0.05, Pearson P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes, Path: Pathological stage, Cli: Clinical stage.
* Only shows the most significant correlation result of EERs/EAGs with either pathological stage or clinical stage according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeStageTypeAnovaPPRBoxplot
chr8:30678340-30679179:-BLCAPathEER1.9234e-023.4631e-030.1460image
ENSG00000104687.11,GSRBLCAPathEAG1.8876e-023.4567e-030.1461image
chr8:30678340-30679179:-KIRCPathEER2.6293e-031.9843e-040.1608image
ENSG00000104687.11,GSRKIRCPathEAG3.4909e-032.8217e-030.1292image
chr8:30678340-30679179:-KIRPPathEER2.1334e-032.1352e-030.1900image
ENSG00000104687.11,GSRKIRPPathEAG2.3165e-032.3275e-030.1884image
chr8:30678340-30679179:-THCAPathEER7.5200e-075.9489e-060.2004image
ENSG00000104687.11,GSRTHCAPathEAG7.5200e-075.9489e-060.2004image


Top

check button Associations of enriched editing regions with cancer survival.
* Pkm<0.05 and Pcox<0.05.
* EER: enriched editing region, EAG: EER-associated genes.
ID_eventscancerTypeIDPkmPcox_continuousHR_continuousKMPlot
chr8:30678340-30679179:-READEER4.3666e-028.3553e-033.8227e+07image
ENSG00000104687.11,GSRREADEAG4.3666e-028.3553e-033.8227e+07image
chr8:30678340-30679179:-UCECEER4.5459e-021.8862e-028.1671e+01image
ENSG00000104687.11,GSRUCECEAG4.5459e-021.8862e-028.1671e+01image

Top

3. Enriched editing regions and immune related genes for GSR


all structure

check button Enriched editing regions and immune related genes.
* First, the associations between enriched editing regions and genes were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the gene relationships with immune were tested by three analyses: whether the gene is an immune gene (InnateDB、Immport、Immunome、Immunogenetic Related Information Source (IRIS)), whether the gene is associated with immune infiltration and whether the gene is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of genes with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeGenebetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr8:30678340-30679179:-BLCAEERENSG00000160710,ADAR0.57964.1274e-312.5112e-330.5535imageNNADARMacrophages_M1GSVA_HALLMARK_MITOTIC_SPINDLE
chr8:30678340-30679179:-BLCAEERENSG00000168394,TAP10.52993.0829e-257.3421e-290.5193imageNNTAP1T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000204267,TAP20.52291.6549e-241.4455e-280.5169imageNNTAP2T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000115415,STAT10.52202.1049e-242.1947e-270.5070imageNNSTAT1T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000115267,IFIH10.51122.1323e-235.9811e-230.4670imageNNIFIH1T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000156587,UBE2L60.51252.3922e-231.8589e-280.5160imageNNNAT_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000123609,NMI0.50836.0524e-233.0170e-320.5456imageNNNAT_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000206337,HCP50.49102.2046e-213.8266e-240.4783imageNNHCP5T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000117228,GBP10.48886.7966e-213.0038e-180.4178imageNNGBP1T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
chr8:30678340-30679179:-BLCAEERENSG00000125347,IRF10.48511.0993e-201.6672e-240.4816imageNNIRF1T_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE

More results



Top

4. Enriched editing regions and immune related splicing for GSR


all structure

check button Enriched editing regions and immune related splicing.
* First, the associations between enriched editing regions and splicing events were tested by QTL and Pearson method (QTL: FDR<0.05 and Pearson: P<0.05).
* Second, the splicing relationships with immune were tested by three analyses: whether the splicing event locates in an immune gene (InnateDB、Immport, Immunome and Immunogenetic Related Information Source (IRIS)), whether the splicing event is associated with immune infiltration and whether the splicing event is related to immune gene sets.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of splicing events with the fraction of different immune cells and the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeSplicingTypeSplicingGeneSplicingChrSplicingPositionbetaFDRPearsonPPearsonRCorrelationPlotRBPRBPtargetsImmuneGeneImmuneFractionHallMark
chr8:30678340-30679179:-
BLCAEERIRENSG00000130175.5chr1911449265:11449882:11450428:11450716-0.57234.7273e-295.5260e-40-0.5988imageNNPRKCSHMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
ENSG00000104687.11,GSR
BLCAEAGIRENSG00000139725.3chr12121777757:121781006:121781082:121781192-0.33247.3809e-094.2172e-16-0.4009imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;FAM120A;FBL;FKBP4;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHSRP;LARP7;LIN28;LIN28B;LSM11;MBNL2;MOV10;MSI1;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RNF219;SAFB2;SBDS;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184NAT_cells_CD4_memory_activatedGSVA_HALLMARK_COMPLEMENT
chr8:30678340-30679179:-
BLCAEERIRENSG00000076928.13chr1941897314:41898113:41898441:41898587-0.34871.8476e-105.5705e-16-0.4094imageNNNAT_cells_CD4_memory_activatedGSVA_HALLMARK_ALLOGRAFT_REJECTION
chr8:30678340-30679179:-
BLCAEERESENSG00000083457.7chr173720306:3720402:3723287:3723383:3723687:37237440.45234.5475e-164.0055e-260.4962imageNNITGAET_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
ENSG00000104687.11,GSR
BLCAEAGIRENSG00000111679.12chr126951261:6951520:6951608:6951731-0.26241.4636e-063.5099e-14-0.4005imageNAIFM1;BCCIP;BUD13;CELF2;CPSF6;CSTF2T;DDX3X;DDX54;DHX9;EIF4A3;ELAVL1;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;GTF2F1;HNRNPA1;HNRNPC;HNRNPK;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;LARP4B;LARP7;LIN28A;LSM11;MSI2;NONO;NOP56;NOP58;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;SAFB2;SF3A3;SF3B4;SLTM;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;U2AF1;U2AF2;UPF1;ZNF184PTPN6Dendritic_cells_activatedGSVA_HALLMARK_COMPLEMENT
chr8:30678340-30679179:-
BLCAEERIRENSG00000139725.3chr12121777757:121781006:121781082:121781192-0.33265.0394e-093.9208e-16-0.4013imageNNNAT_cells_CD4_memory_activatedGSVA_HALLMARK_COMPLEMENT
ENSG00000104687.11,GSR
BLCAEAGMEXENSG00000140105.13chr14100342397:100342571:100343274:100343387:100369086:100369258:100375282:100375333-0.39993.8265e-123.0247e-19-0.4299imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CAPRIN1;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G1;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP4B;LARP7;LIN28;LIN28A;LIN28B;LSM11;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RNF219;SAFB2;SBDS;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZC3H7B;ZNF184WARST_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
chr8:30678340-30679179:-
BLCAEERMEXENSG00000140105.13chr14100342397:100342571:100343274:100343387:100369086:100369258:100375282:100375333-0.39823.5234e-124.7707e-19-0.4278imageNNWARST_cells_CD4_memory_activatedGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSE
ENSG00000104687.11,GSR
BLCAEAGIRENSG00000130175.5chr1911449265:11449882:11450428:11450716-0.57185.2566e-296.6102e-40-0.5983imageNACIN1;ADAR;AIFM1;AUH;BCCIP;BUD13;CAPRIN1;CBX7;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;EIF4A3;EIF4G1;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FKBP4;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHDRBS2;KHDRBS3;KHSRP;LARP4B;LARP7;LIN28;LIN28A;LIN28B;LSM11;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;QKI;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RBM47;RBM5;RNF219;SAFB2;SBDS;SF3A3;SF3B4;SLBP;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARBP2;TARDBP;TIA1;TIAL1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZNF184PRKCSHMacrophages_M1GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE
ENSG00000104687.11,GSR
BLCAEAGIRENSG00000076928.13chr1941897314:41898113:41898441:41898587-0.34822.7835e-106.1714e-16-0.4088imageNADAR;AIFM1;AUH;BCCIP;BUD13;CELF2;CNBP;CPSF6;CSTF2T;DDX3X;DDX42;DDX54;DGCR8;DHX9;DICER1;DKC1;EIF4A3;EIF4G2;ELAVL1;ELAVL3;EWSR1;FAM120A;FBL;FKBP4;FMR1;FTO;FUS;FXR1;FXR2;GNL3;GTF2F1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPK;HNRNPL;HNRNPM;IGF2BP1;IGF2BP2;IGF2BP3;ILF3;KHDRBS1;KHSRP;LARP4B;LARP7;LIN28;LIN28A;LIN28B;LSM11;MOV10;MSI1;MSI2;NONO;NOP56;NOP58;NPM1;NUMA1;PCBP2;PRPF8;PTBP1;RANGAP1;RBFOX2;RBM10;RBM22;RBM27;RNF219;SAFB2;SBDS;SF3A3;SF3B4;SLTM;SMNDC1;SND1;SRSF1;SRSF3;SRSF7;SRSF9;TAF15;TARDBP;TIA1;TNRC6A;TRA2A;TROVE2;U2AF1;U2AF2;UPF1;XRN2;YTHDC1;YTHDF1;YWHAG;ZFP36;ZNF184NAT_cells_CD4_memory_activatedGSVA_HALLMARK_ALLOGRAFT_REJECTION

More results



Top

5. Enriched editing regions and immune infiltration for GSR


all structure

check button Associations of enriched editing regions with immune infiltration.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the fraction of different immune cells according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerTypeIDImmuneCellPRCorrelationPlot
chr8:30678340-30679179:-ACCEERB_cells_memory1.2263e-020.2823image
ENSG00000104687.11,GSRACCEAGB_cells_memory1.2263e-020.2823image
chr8:30678340-30679179:-BLCAEERT_cells_CD4_memory_activated1.4094e-160.3982image
ENSG00000104687.11,GSRBLCAEAGT_cells_CD4_memory_activated1.5573e-160.3977image
chr8:30678340-30679179:-BRCAEERMacrophages_M15.8021e-060.1373image
ENSG00000104687.11,GSRBRCAEAGMacrophages_M16.6214e-060.1364image
chr8:30678340-30679179:-CESCEERMacrophages_M01.3277e-04-0.2174image
ENSG00000104687.11,GSRCESCEAGMacrophages_M01.1858e-04-0.2190image
chr8:30678340-30679179:-COADEERMacrophages_M18.0125e-030.1596image
ENSG00000104687.11,GSRCOADEAGNeutrophils4.0169e-040.2119image
chr8:30678340-30679179:-DLBCEERMacrophages_M11.9250e-030.4409image
ENSG00000104687.11,GSRDLBCEAGMacrophages_M11.9250e-030.4409image
chr8:30678340-30679179:-ESCAEERDendritic_cells_resting2.0446e-02-0.1826image
chr8:30692032-30692721:-ESCAEERNK_cells_activated6.4726e-040.6964image
ENSG00000104687.11,GSRESCAEAGDendritic_cells_resting2.0103e-02-0.1831image
chr8:30678340-30679179:-GBMEERMast_cells_resting8.3461e-040.2561image
ENSG00000104687.11,GSRGBMEAGMast_cells_resting8.3461e-040.2561image
chr8:30678340-30679179:-HNSCEERMacrophages_M13.5489e-060.2060image
ENSG00000104687.11,GSRHNSCEAGMacrophages_M13.5489e-060.2060image
ENSG00000104687.11,GSRKICHEAGPlasma_cells2.0313e-020.2873image
chr8:30678340-30679179:-KIRCEERMacrophages_M14.6885e-060.2312image
ENSG00000104687.11,GSRKIRCEAGMacrophages_M17.4040e-060.2265image
chr8:30678340-30679179:-KIRPEERMacrophages_M12.3113e-060.2747image
ENSG00000104687.11,GSRKIRPEAGMacrophages_M12.3206e-060.2746image
chr8:30678340-30679179:-LAMLEERB_cells_naive3.4010e-040.3028image
ENSG00000104687.11,GSRLAMLEAGB_cells_naive3.9228e-040.2998image
chr8:30678340-30679179:-LGGEERMacrophages_M14.2232e-050.1772image
ENSG00000104687.11,GSRLGGEAGMacrophages_M14.2232e-050.1772image
chr8:30678340-30679179:-LIHCEERMacrophages_M19.5260e-050.2007image
ENSG00000104687.11,GSRLIHCEAGMacrophages_M19.5260e-050.2007image
chr8:30678340-30679179:-LUADEERT_cells_CD4_memory_activated3.9650e-080.2386image
ENSG00000104687.11,GSRLUADEAGT_cells_CD4_memory_activated4.1397e-080.2383image
chr8:30678340-30679179:-LUSCEERT_cells_CD4_memory_activated9.7384e-110.2847image
ENSG00000104687.11,GSRLUSCEAGT_cells_CD4_memory_activated9.4431e-110.2849image
chr8:30678340-30679179:-MESOEERT_cells_CD81.2024e-020.2762image
ENSG00000104687.11,GSRMESOEAGT_cells_CD81.2024e-020.2762image
chr8:30678340-30679179:-OVEERT_cells_follicular_helper1.2524e-050.2526image
ENSG00000104687.11,GSROVEAGT_cells_follicular_helper1.2550e-050.2525image
chr8:30678340-30679179:-PAADEERDendritic_cells_activated1.5172e-030.2360image
ENSG00000104687.11,GSRPAADEAGDendritic_cells_activated1.5172e-030.2360image
chr8:30678340-30679179:-PCPGEERT_cells_regulatory_(Tregs)1.4464e-050.3154image
ENSG00000104687.11,GSRPCPGEAGT_cells_regulatory_(Tregs)1.4464e-050.3154image
chr8:30678340-30679179:-PRADEERMacrophages_M12.1547e-060.2103image
ENSG00000104687.11,GSRPRADEAGMacrophages_M12.3239e-060.2096image
chr8:30678340-30679179:-READEERMacrophages_M24.4935e-020.2074image
ENSG00000104687.11,GSRREADEAGMacrophages_M24.4935e-020.2074image
chr8:30678340-30679179:-SARCEERMacrophages_M15.1010e-050.2499image
ENSG00000104687.11,GSRSARCEAGMacrophages_M15.2888e-050.2494image
chr8:30678340-30679179:-SKCMEERT_cells_CD87.1691e-130.3226image
ENSG00000104687.11,GSRSKCMEAGT_cells_CD86.3079e-130.3234image
chr8:30678340-30679179:-STADEERMacrophages_M12.0174e-040.1916image
chr8:30692032-30692721:-STADEERT_cells_CD4_memory_activated2.7274e-020.3092image
ENSG00000104687.11,GSRSTADEAGMacrophages_M12.0183e-040.1916image
chr8:30678340-30679179:-TGCTEERMacrophages_M21.2648e-17-0.6153image
ENSG00000104687.11,GSRTGCTEAGMacrophages_M21.2648e-17-0.6153image
chr8:30678340-30679179:-THCAEERB_cells_naive5.7383e-070.2205image
ENSG00000104687.11,GSRTHCAEAGB_cells_naive5.7383e-070.2205image
chr8:30678340-30679179:-THYMEERMacrophages_M11.5470e-050.3864image
ENSG00000104687.11,GSRTHYMEAGMacrophages_M11.5470e-050.3864image
chr8:30678340-30679179:-UCECEERDendritic_cells_activated1.1418e-040.2852image
ENSG00000104687.11,GSRUCECEAGDendritic_cells_activated7.6800e-050.2912image
chr8:30678340-30679179:-UCSEERMast_cells_resting3.0311e-020.2897image
ENSG00000104687.11,GSRUCSEAGMast_cells_resting3.0294e-020.2898image
ENSG00000104687.11,GSRUVMEAGT_cells_CD83.6835e-030.3251image


Top

6. Enriched editing regions and immune gene sets for GSR


all structure

check button Correlation of enriched editing regions with epithelial-mesenchymal transition.
* First, the differences of enriched editing regions between Epi and Mes groups (defined by KS-test) were compared (P<0.05 and Informative number >=20).
* Second, the correlations between enriched editing regions and gene set score of HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly edited between Epi and Mes group.
ID_eventscancerTypeE2M_PBoxplotCorPCorRCorrelationPlot


Top

check button Correlations of enriched editing regions with hypoxic.
* First, there are four hypoxia scores used in the database. The first three hypoxic scores were calculated on three gene sets of Buffa, Ragnum and Winter based on one previous study (PMID: 32024819). One last hypoxia score was defined on HALLMARK_HYPOXIA by GSVA method.
* Second, the correlations enriched editing regions with the four hypoxic scores were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the EERs/EAGs significantly correlated with all four hypoxia gene set scores. For more results, please go to download page.
ID_eventscancerTypeBuffa_P Buffa_R Ragnum_P Ragnum_R Winter_P Winter_R HALLMARK_P HALLMARK_R CorrelationPlot
chr8:30678340-30679179:-BLCAEER1.2428e-100.31524.8528e-070.24904.8288e-090.28807.2985e-110.3190image
ENSG00000104687.11,GSRBLCAEAG1.3510e-100.31464.7903e-070.24925.2018e-090.28758.9214e-110.3176image
chr8:30678340-30679179:-GBMEER2.0238e-02-0.17964.9885e-02-0.15205.5112e-04-0.26453.7943e-02-0.1608image
ENSG00000104687.11,GSRGBMEAG2.0238e-02-0.17964.9885e-02-0.15205.5112e-04-0.26453.7943e-02-0.1608image
chr8:30678340-30679179:-LIHCEER2.0066e-03-0.15953.7214e-05-0.21189.2434e-05-0.20102.6511e-020.1149image
ENSG00000104687.11,GSRLIHCEAG2.0066e-03-0.15953.7214e-05-0.21189.2434e-05-0.20102.6511e-020.1149image
chr8:30678340-30679179:-LUADEER1.2575e-090.26301.1228e-130.31889.8649e-100.26464.4243e-020.0885image
ENSG00000104687.11,GSRLUADEAG1.2565e-090.26301.0724e-130.31909.6667e-100.26484.5523e-020.0880image
chr8:30678340-30679179:-PAADEER1.0986e-050.32301.0534e-050.32361.8555e-050.31494.1106e-040.2620image
ENSG00000104687.11,GSRPAADEAG1.0986e-050.32301.0534e-050.32361.8555e-050.31494.1106e-040.2620image


Top

check button Associations of enriched editing regions with hallmark gene sets from MSigDB.
* P<0.05 and Informative number >=20.
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the scores of 50 hallmark genesets according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerHallmarkTypeTypePRCorrelationPlot
ENSG00000104687.11,GSRACCGSVA_HALLMARK_PROTEIN_SECRETIONEAG1.6622e-030.3504image
chr8:30678340-30679179:-ACCGSVA_HALLMARK_PROTEIN_SECRETIONEER1.6622e-030.3504image
ENSG00000104687.11,GSRBLCAGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEAG1.7579e-290.5243image
chr8:30678340-30679179:-BLCAGSVA_HALLMARK_INTERFERON_GAMMA_RESPONSEEER1.5092e-290.5248image
chr8:30678340-30679179:-BRCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.1738e-370.3737image
ENSG00000104687.11,GSRBRCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG4.8918e-370.3728image
chr8:30678340-30679179:-CESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.3014e-200.4969image
ENSG00000104687.11,GSRCESCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.9433e-200.4957image
ENSG00000104687.11,GSRCHOLGSVA_HALLMARK_DNA_REPAIREAG1.9477e-02-0.3931image
chr8:30678340-30679179:-CHOLGSVA_HALLMARK_DNA_REPAIREER1.9477e-02-0.3931image
chr8:30678340-30679179:-COADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER7.9084e-050.2357image
ENSG00000104687.11,GSRCOADGSVA_HALLMARK_BILE_ACID_METABOLISMEAG1.5510e-04-0.2262image
ENSG00000104687.11,GSRDLBCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.0858e-030.4378image
chr8:30678340-30679179:-DLBCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.0858e-030.4378image
chr8:30692032-30692721:-ESCAGSVA_HALLMARK_ANDROGEN_RESPONSEEER1.4333e-02-0.5384image
ENSG00000104687.11,GSRESCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG5.7881e-050.3114image
chr8:30678340-30679179:-ESCAGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER5.3757e-050.3127image
chr8:30678340-30679179:-GBMGSVA_HALLMARK_ANGIOGENESISEER5.4633e-04-0.2647image
ENSG00000104687.11,GSRGBMGSVA_HALLMARK_ANGIOGENESISEAG5.4633e-04-0.2647image
ENSG00000104687.11,GSRHNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG3.1483e-220.4157image
chr8:30678340-30679179:-HNSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER3.1483e-220.4157image
ENSG00000104687.11,GSRKICHGSVA_HALLMARK_PEROXISOMEEAG4.0655e-030.3517image
chr8:30678340-30679179:-KIRCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER4.9920e-120.3428image
ENSG00000104687.11,GSRKIRCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.0679e-120.3388image
ENSG00000104687.11,GSRKIRPGSVA_HALLMARK_PANCREAS_BETA_CELLSEAG4.5223e-070.2926image
chr8:30678340-30679179:-KIRPGSVA_HALLMARK_PANCREAS_BETA_CELLSEER4.5072e-070.2926image
ENSG00000104687.11,GSRLAMLGSVA_HALLMARK_ADIPOGENESISEAG4.1433e-05-0.3439image
chr8:30678340-30679179:-LAMLGSVA_HALLMARK_ADIPOGENESISEER3.7560e-05-0.3457image
ENSG00000104687.11,GSRLGGGSVA_HALLMARK_ANDROGEN_RESPONSEEAG8.4080e-060.1925image
chr8:30678340-30679179:-LGGGSVA_HALLMARK_ANDROGEN_RESPONSEEER8.4080e-060.1925image
chr8:30678340-30679179:-LIHCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.4900e-100.3238image
ENSG00000104687.11,GSRLIHCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.4900e-100.3238image
chr8:30678340-30679179:-LUADGSVA_HALLMARK_E2F_TARGETSEER4.0590e-150.3361image
ENSG00000104687.11,GSRLUADGSVA_HALLMARK_E2F_TARGETSEAG4.2799e-150.3358image
ENSG00000104687.11,GSRLUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.6958e-280.4682image
chr8:30678340-30679179:-LUSCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.5250e-280.4686image
chr8:30678340-30679179:-MESOGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEER3.4429e-030.3194image
ENSG00000104687.11,GSRMESOGSVA_HALLMARK_TNFA_SIGNALING_VIA_NFKBEAG3.4429e-030.3194image
ENSG00000104687.11,GSROVGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG7.3912e-190.4878image
chr8:30678340-30679179:-OVGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER7.6509e-190.4876image
ENSG00000104687.11,GSRPAADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.7357e-090.4320image
chr8:30678340-30679179:-PAADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.7357e-090.4320image
ENSG00000104687.11,GSRPCPGGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.8330e-090.4091image
chr8:30678340-30679179:-PCPGGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER9.8330e-090.4091image
ENSG00000104687.11,GSRPRADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.3975e-200.3999image
chr8:30678340-30679179:-PRADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.3013e-200.4002image
ENSG00000104687.11,GSRREADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG6.2615e-040.3464image
chr8:30678340-30679179:-READGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER6.2615e-040.3464image
chr8:30678340-30679179:-SARCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.7787e-080.3423image
ENSG00000104687.11,GSRSARCGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.7149e-080.3427image
chr8:30678340-30679179:-SKCMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER9.4357e-190.3920image
ENSG00000104687.11,GSRSKCMGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG1.0891e-180.3914image
ENSG00000104687.11,GSRSTADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG6.0594e-150.3898image
chr8:30692032-30692721:-STADGSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITIONEER3.1784e-02-0.3011image
chr8:30678340-30679179:-STADGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER1.2057e-150.3990image
chr8:30678340-30679179:-TGCTGSVA_HALLMARK_ANGIOGENESISEER3.7849e-13-0.5393image
ENSG00000104687.11,GSRTGCTGSVA_HALLMARK_ANGIOGENESISEAG3.7849e-13-0.5393image
ENSG00000104687.11,GSRTHCAGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEAG2.6182e-250.4402image
chr8:30678340-30679179:-THCAGSVA_HALLMARK_ESTROGEN_RESPONSE_LATEEER2.6182e-250.4402image
ENSG00000104687.11,GSRTHYMGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEAG1.5606e-050.3862image
chr8:30678340-30679179:-THYMGSVA_HALLMARK_ESTROGEN_RESPONSE_EARLYEER1.5606e-050.3862image
ENSG00000104687.11,GSRUCECGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG2.7267e-100.4496image
chr8:30678340-30679179:-UCECGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER2.9225e-100.4501image
ENSG00000104687.11,GSRUCSGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEAG9.6207e-040.4293image
chr8:30678340-30679179:-UCSGSVA_HALLMARK_INTERFERON_ALPHA_RESPONSEEER9.6111e-040.4293image
ENSG00000104687.11,GSRUVMGSVA_HALLMARK_COAGULATIONEAG4.9861e-040.3851image


Top

7. Enriched editing regions and drugs for GSR


all structure

check button Correlations between enriched editing regions and drug sensitivity.
* First, the drug sensitivity (IS50) was estimated on 84 drugs by pRRophetic package.
* Second, the correlations between editing enriched regions and drug sensitivity were analyzed (P<0.05 and Informative number >=20).
* EER: enriched editing region, EAG: EER-associated genes.
* Only shows the most significant correlation result of EERs/EAGs with the IS50 scores of 84 drugs according to correlation coefficient (R). For more results, please go to download page.
ID_eventscancerDrugTypePRCorrelationPlot
ENSG00000104687.11,GSRACCLFM.A13EAG1.4289e-020.2764image
chr8:30678340-30679179:-ACCLFM.A13EER1.4289e-020.2764image
ENSG00000104687.11,GSRBLCACGP.60474EAG3.7869e-17-0.4051image
chr8:30678340-30679179:-BLCACGP.60474EER3.7010e-17-0.4052image
ENSG00000104687.11,GSRBRCAAxitinibEAG6.0734e-090.1756image
chr8:30678340-30679179:-BRCAAxitinibEER6.4682e-090.1753image
ENSG00000104687.11,GSRCESCFH535EAG2.8867e-070.2892image
chr8:30678340-30679179:-CESCCI.1040EER2.4069e-07-0.2910image
chr8:30678340-30679179:-CHOLAMG.706EER6.6276e-030.4504image
ENSG00000104687.11,GSRCHOLAMG.706EAG6.6276e-030.4504image
chr8:30678340-30679179:-COADGefitinibEER4.2124e-06-0.2734image
ENSG00000104687.11,GSRCOADGefitinibEAG1.1279e-06-0.2886image
ENSG00000104687.11,GSRDLBCDoxorubicinEAG1.0864e-040.5346image
chr8:30678340-30679179:-DLBCDoxorubicinEER1.0864e-040.5346image
chr8:30692032-30692721:-ESCABortezomibEER5.9893e-03-0.5917image
ENSG00000104687.11,GSRESCAABT.263EAG4.1339e-030.2256image
chr8:30678340-30679179:-ESCAABT.263EER3.5967e-030.2289image
chr8:30678340-30679179:-GBMCEP.701EER4.8958e-050.3088image
ENSG00000104687.11,GSRGBMCEP.701EAG4.8958e-050.3088image
ENSG00000104687.11,GSRHNSCFH535EAG1.5856e-070.2323image
chr8:30678340-30679179:-HNSCFH535EER1.5856e-070.2323image
chr8:30678340-30679179:-KIRCCamptothecinEER1.2513e-06-0.2444image
ENSG00000104687.11,GSRKIRCCamptothecinEAG2.9570e-06-0.2359image
ENSG00000104687.11,GSRKIRPCCT018159EAG1.5996e-080.3258image
chr8:30678340-30679179:-KIRPCCT018159EER1.5950e-080.3258image
chr8:30678340-30679179:-LAMLBMS.509744EER4.7828e-050.3413image
ENSG00000104687.11,GSRLAMLBMS.509744EAG4.8088e-050.3412image
chr8:30678340-30679179:-LGGBMS.754807EER1.3089e-040.1657image
ENSG00000104687.11,GSRLGGBMS.754807EAG1.3089e-040.1657image
chr8:30678340-30679179:-LIHCBleomycinEER1.6102e-110.3426image
ENSG00000104687.11,GSRLIHCBleomycinEAG1.6102e-110.3426image
ENSG00000104687.11,GSRLUADCMKEAG6.8551e-08-0.2345image
chr8:30678340-30679179:-LUADCMKEER7.3283e-08-0.2340image
chr8:30678340-30679179:-LUSCGemcitabineEER1.3273e-08-0.2512image
ENSG00000104687.11,GSRLUSCGemcitabineEAG1.4204e-08-0.2507image
chr8:30678340-30679179:-MESOJNK.9LEER2.6000e-02-0.2458image
ENSG00000104687.11,GSRMESOJNK.9LEAG2.6000e-02-0.2458image
ENSG00000104687.11,GSROVGDC0941EAG3.3380e-060.2682image
chr8:30678340-30679179:-OVGDC0941EER3.3258e-060.2682image
chr8:30678340-30679179:-PAADFTI.277EER3.9991e-04-0.2625image
ENSG00000104687.11,GSRPAADFTI.277EAG3.9991e-04-0.2625image
chr8:30678340-30679179:-PCPGMidostaurinEER1.8368e-070.3750image
ENSG00000104687.11,GSRPCPGMidostaurinEAG1.8368e-070.3750image
chr8:30678340-30679179:-PRADJNK.Inhibitor.VIIIEER7.0762e-16-0.3506image
ENSG00000104687.11,GSRPRADJNK.Inhibitor.VIIIEAG3.4760e-16-0.3541image
chr8:30678340-30679179:-READCGP.60474EER9.3002e-04-0.3360image
ENSG00000104687.11,GSRREADCGP.60474EAG9.3002e-04-0.3360image
chr8:30678340-30679179:-SARCCMKEER1.2467e-050.2688image
ENSG00000104687.11,GSRSARCCMKEAG1.0673e-050.2708image
chr8:30678340-30679179:-SKCMJNK.9LEER4.3060e-07-0.2304image
ENSG00000104687.11,GSRSKCMJNK.9LEAG3.9331e-07-0.2311image
chr8:30692032-30692721:-STADKIN001.135EER2.1325e-020.3217image
ENSG00000104687.11,GSRSTADJNK.Inhibitor.VIIIEAG2.7974e-03-0.1546image
chr8:30678340-30679179:-STADJNK.Inhibitor.VIIIEER2.3916e-03-0.1570image
chr8:30678340-30679179:-TGCTFTI.277EER3.5170e-110.4985image
ENSG00000104687.11,GSRTGCTFTI.277EAG3.5170e-110.4985image
chr8:30678340-30679179:-THCACI.1040EER8.9937e-22-0.4092image
ENSG00000104687.11,GSRTHCACI.1040EAG8.9937e-22-0.4092image
ENSG00000104687.11,GSRTHYMAxitinibEAG4.9971e-080.4763image
chr8:30678340-30679179:-THYMAxitinibEER4.9971e-080.4763image
chr8:30678340-30679179:-UCECJNK.Inhibitor.VIIIEER6.3258e-06-0.3312image
ENSG00000104687.11,GSRUCECJNK.Inhibitor.VIIIEAG8.8155e-06-0.3254image
chr8:30678340-30679179:-UCSCGP.60474EER2.0532e-03-0.4034image
ENSG00000104687.11,GSRUCSCGP.60474EAG2.0526e-03-0.4034image
ENSG00000104687.11,GSRUVMBortezomibEAG2.8343e-05-0.4551image


Top

check button EAGs targeted by drugs from DrugBank database.
* EAG: EER-associated genes.
EERENSTUniprotIDDrugBankIDDrugDrugType
chr8:30678340-30679179:-ENST00000221130.8P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30678340-30679179:-ENST00000221130.8P00390DB00157NADHSmallMoleculeDrug
chr8:30678340-30679179:-ENST00000221130.8P00390DB00262CarmustineSmallMoleculeDrug
chr8:30678340-30679179:-ENST00000221130.8P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30678340-30679179:-ENST00000221130.8P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30678340-30679179:-ENST00000221130.8P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30678340-30679179:-ENST00000221130.8P00390DB09130CopperSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB00157NADHSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB00262CarmustineSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000221130.8P00390DB09130CopperSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB00157NADHSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB00262CarmustineSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000537535.4P00390DB09130CopperSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB00157NADHSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB00262CarmustineSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000541648.4P00390DB09130CopperSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB00157NADHSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB00262CarmustineSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30692032-30692721:-ENST00000546342.4P00390DB09130CopperSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB00157NADHSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB00262CarmustineSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000221130.8P00390DB09130CopperSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB00157NADHSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB00262CarmustineSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000537535.4P00390DB09130CopperSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB00157NADHSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB00262CarmustineSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000541648.4P00390DB09130CopperSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB00143GlutathioneSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB00157NADHSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB00262CarmustineSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB03147Flavin adenine dinucleotideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB03310Glutathione disulfideSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB09061CannabidiolSmallMoleculeDrug
chr8:30697535-30697985:-ENST00000546342.4P00390DB09130CopperSmallMoleculeDrug